Chromatin Dynamics in Digestive System Cancer: Commander and Regulator

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Aug 15

PMID 35965507

Authors

Zeru Li

Bangbo Zhao

Cheng Qin

Yuanyang Wang

Tianhao Li

Weibin Wang

Affiliations

Soon will be listed here.

Abstract

Digestive system tumors have a poor prognosis due to complex anatomy, insidious onset, challenges in early diagnosis, and chemoresistance. Epidemiological statistics has verified that digestive system tumors rank first in tumor-related death. Although a great number of studies are devoted to the molecular biological mechanism, early diagnostic markers, and application of new targeted drugs in digestive system tumors, the therapeutic effect is still not satisfactory. Epigenomic alterations including histone modification and chromatin remodeling are present in human cancers and are now known to cooperate with genetic changes to drive the cancer phenotype. Chromatin is the carrier of genetic information and consists of DNA, histones, non-histone proteins, and a small amount of RNA. Chromatin and nucleosomes control the stability of the eukaryotic genome and regulate DNA processes such as transcription, replication, and repair. The dynamic structure of chromatin plays a key role in this regulatory function. Structural fluctuations expose internal DNA and thus provide access to the nuclear machinery. The dynamic changes are affected by various complexes and epigenetic modifications. Variation of chromatin dynamics produces early and superior regulation of the expression of related genes and downstream pathways, thereby controlling tumor development. Intervention at the chromatin level can change the process of cancer earlier and is a feasible option for future tumor diagnosis and treatment. In this review, we introduced chromatin dynamics including chromatin remodeling, histone modifications, and chromatin accessibility, and current research on chromatin regulation in digestive system tumors was also summarized.

Citing Articles

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.

Tufail M, Jiang C, Li N Mil Med Res. 2025; 12(1):7.

PMID: 39934876 PMC: 11812268. DOI: 10.1186/s40779-025-00595-2.

DNA choreography: correlating mobility and organization of DNA across different resolutions from loops to chromosomes.

Pabba M, Meyer J, Celikay K, Schermelleh L, Rohr K, Cardoso M Histochem Cell Biol. 2024; 162(1-2):109-131.

PMID: 38758428 PMC: 11227476. DOI: 10.1007/s00418-024-02285-x.

Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.

Hung Y, Wang H, Pan M, Chen L J Pers Med. 2024; 14(3).

PMID: 38540967 PMC: 10971448. DOI: 10.3390/jpm14030224.

References

Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X . USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ. Cancer Res. 2020; 80(11):2204-2216. DOI: 10.1158/0008-5472.CAN-19-2388. View

Zentner G, Henikoff S . Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol. 2013; 20(3):259-66. DOI: 10.1038/nsmb.2470. View

Sungalee S, Liu Y, Lambuta R, Katanayeva N, Donaldson Collier M, Tavernari D . Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci. Nat Genet. 2021; 53(5):650-662. DOI: 10.1038/s41588-021-00842-x. View

Weichert W, Roske A, Niesporek S, Noske A, Buckendahl A, Dietel M . Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res. 2008; 14(6):1669-77. DOI: 10.1158/1078-0432.CCR-07-0990. View

Sung M, Guertin M, Baek S, Hager G . DNase footprint signatures are dictated by factor dynamics and DNA sequence. Mol Cell. 2014; 56(2):275-285. PMC: 4272573. DOI: 10.1016/j.molcel.2014.08.016. View

Chan-On W, Nairismagi M, Ong C, Lim W, Dima S, Pairojkul C . Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet. 2013; 45(12):1474-8. DOI: 10.1038/ng.2806. View

Jiang P, Wang H, Zheng J, Han Y, Huang H, Qian P . Epigenetic regulation of hematopoietic stem cell homeostasis. Blood Sci. 2022; 1(1):19-28. PMC: 8974946. DOI: 10.1097/BS9.0000000000000018. View

Li Y, Seto E . HDACs and HDAC Inhibitors in Cancer Development and Therapy. Cold Spring Harb Perspect Med. 2016; 6(10). PMC: 5046688. DOI: 10.1101/cshperspect.a026831. View

Hesselberth J, Chen X, Zhang Z, Sabo P, Sandstrom R, Reynolds A . Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat Methods. 2009; 6(4):283-9. PMC: 2668528. DOI: 10.1038/nmeth.1313. View

10.

Xiao W, Zhou Q, Wen X, Wang R, Liu R, Wang T . Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy. Front Pharmacol. 2021; 12:702360. PMC: 8484527. DOI: 10.3389/fphar.2021.702360. View

11.

Butta N, Larrucea S, Alonso S, Rodriguez R, Arias-Salgado E, Ayuso M . Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter. BMC Mol Biol. 2006; 7:17. PMC: 1481587. DOI: 10.1186/1471-2199-7-17. View

12.

Tsukada Y, Fang J, Erdjument-Bromage H, Warren M, Borchers C, Tempst P . Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2005; 439(7078):811-6. DOI: 10.1038/nature04433. View

13.

Gayther S, Batley S, LINGER L, BANNISTER A, Thorpe K, Chin S . Mutations truncating the EP300 acetylase in human cancers. Nat Genet. 2000; 24(3):300-3. DOI: 10.1038/73536. View

14.

Kunz K, Piller T, Muller S . SUMO-specific proteases and isopeptidases of the SENP family at a glance. J Cell Sci. 2018; 131(6). DOI: 10.1242/jcs.211904. View

15.

Shin H, Kim G, Kim S, Sim J, Choi J, Kim M . Chromatin accessibility of circulating CD8 T cells predicts treatment response to PD-1 blockade in patients with gastric cancer. Nat Commun. 2021; 12(1):975. PMC: 7881150. DOI: 10.1038/s41467-021-21299-w. View

16.

Paull T, Rogakou E, Yamazaki V, Kirchgessner C, Gellert M, Bonner W . A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000; 10(15):886-95. DOI: 10.1016/s0960-9822(00)00610-2. View

17.

Kunert N, Brehm A . Novel Mi-2 related ATP-dependent chromatin remodelers. Epigenetics. 2009; 4(4):209-11. DOI: 10.4161/epi.8933. View

18.

Lohr D, VAN Holde K . Yeast chromatin subunit structure. Science. 1975; 188(4184):165-6. DOI: 10.1126/science.1090006. View

19.

Nan X, Ng H, Johnson C, Laherty C, Turner B, Eisenman R . Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998; 393(6683):386-9. DOI: 10.1038/30764. View

20.

Dorschner M, Hawrylycz M, Humbert R, Wallace J, Shafer A, Kawamoto J . High-throughput localization of functional elements by quantitative chromatin profiling. Nat Methods. 2005; 1(3):219-25. DOI: 10.1038/nmeth721. View